Evidence check: TCF7L2 in the context of Fruchtbarkeit

TCF7L2 is a well-studied gene strongly associated with type 2 diabetes risk (strong GWAS evidence). In the context of fertility, the evidence is much weaker. Some studies suggest a possible link via insulin resistance and PCOS, since TCF7L2 variants affect glucose metabolism. However, these are indirect, mechanistic hints rather than direct evidence for impaired fertility. Consumer DNA tests like MyBody-X can analyze TCF7L2 variants, but interpretation for fertility is not clinically validated. Effect sizes are small, and individual results should not guide reproductive decisions. A physician or fertility specialist can provide comprehensive evaluation. Evidence: mixed (strong for diabetes, weak for fertility).